tiprankstipranks
Trending News
More News >
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market

Xenetic Biosciences (XBIO) Financial Statements

Compare
340 Followers

Xenetic Biosciences Financial Overview

Xenetic Biosciences's market cap is currently $5.09M. The company's EPS TTM is $-0.33; its P/E ratio is -1.08; Xenetic Biosciences is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.50M$ 2.54M$ 1.71M$ 1.16M$ 436.94K
Gross Profit$ 2.50M$ 2.54M$ 1.71M$ 1.16M$ 436.94K
Operating Income$ -4.20M$ -4.52M$ -6.72M$ -5.75M$ -13.94M
EBITDA$ -4.05M$ -4.52M$ -6.69M$ -5.71M$ -4.67M
Net Income$ -3.96M$ -4.13M$ -6.55M$ -5.65M$ -10.89M
Balance Sheet
Cash & Short-Term Investments$ 6.17M$ 8.98M$ 13.10M$ 18.24M$ 11.53M
Total Assets$ 6.90M$ 10.61M$ 14.72M$ 19.82M$ 13.18M
Total Debt$ 0.00$ 0.00$ 0.00$ 27.04K$ 62.52K
Net Debt$ -6.17M$ -8.98M$ -13.10M$ -18.22M$ -11.47M
Total Liabilities$ 894.26K$ 809.59K$ 1.07M$ 1.42M$ 963.97K
Stockholders' Equity$ 6.01M$ 9.80M$ 13.65M$ 18.39M$ 12.22M
Cash Flow
Free Cash Flow$ -2.82M$ -4.11M$ -5.15M$ -4.74M$ -4.27M
Operating Cash Flow$ -2.82M$ -4.11M$ -4.65M$ -4.74M$ -4.27M
Investing Cash Flow$ 0.00$ 0.00$ -500.00K$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 11.45M$ 5.43M
Currency in USD

Xenetic Biosciences Earnings and Revenue History

Xenetic Biosciences Debt to Assets

Xenetic Biosciences Cash Flow

Xenetic Biosciences Forecast EPS vs Actual EPS